When we talk about artificial intelligence (AI) – which we have done lot recently, including my outline on The Conversation of liability and regulation issues – what do we actually mean?
We’ve already started discussions around driverless cars, but there’s so much more to deal with when it comes to artificial intelligence.
Thousands of fixed dose combination (FDC) drugs – where two or more drugs are combined in a set ratio in a single dose form, usually a tablet or capsule – are formulated, made and sold within India.
Despite worries about threats from artificial intelligence, debates about the proper role of government regulation of AI have generally been lacking.
A society that denies us the right to put cannabis in our brain, and forces us to pee on demand to prove we haven’t, is a society more likely to tell us we can’t use intelligence enhancers and mood modifiers and willing to use new technologies of repression to ensure we don’t.
What if the Industrial Revolution never ended? What if Da Vinci was not merely a creative genius but had many teachers due to the influx of Greek scholars after the fall of the Byzantium Empire? What if the future is just a stepwise evolution from the nearest-neighbor in systematic composition while directed by correspondence, one recombination after another, pushing along what has already happened while shaped by the pull of the potential?
BioViva is a new company offering experimental medical services outside US borders.
It’s supposedly getting easier for innovative drugs for rare diseases like Duchenne muscular dystrophy to reach the market. So why, asks Andy Extance, is hesitancy still proving devastating to desperate families?
As the old social bonds unravel, how can we balance free expression against security?
The Digital Citizen’s Alliance has provided an update to their study which analyzes online black markets, focusing on the sales of illegal drugs via the darknet.